Legend Biotech (LEGN) Raw Materials (2022 - 2025)

Legend Biotech has reported Raw Materials for 4 years, with the latest figure at $23.2 million in Q1 2025.

• For the quarter ending Q1 2025, Raw Materials rose 30.06% year-over-year to $23.2 million; the trailing twelve-month figure through Mar 2025 stood at $23.2 million (up 30.06% YoY), and the FY2024 full-year result was $17.5 million, up 32.68% from the prior year.
• Raw Materials for Q1 2025 stood at $23.2 million, up from $17.5 million in the prior quarter.
• The five-year high for Raw Materials was $23.2 million in Q1 2025, with the low at $7.0 million in Q4 2022.
• Historically, Raw Materials has averaged $14.7 million across 4 years, with a median of $14.0 million in 2024.
• Annual changes were most pronounced in 2023 — Raw Materials soared 88.22% — and 2025, when it jumped 30.06%.
• Legend Biotech's Raw Materials stood at $7.0 million in 2022, then soared by 88.22% to $13.2 million in 2023, then surged by 32.68% to $17.5 million in 2024, then surged by 32.78% to $23.2 million in 2025.
• The last three Raw Materials figures came in at $23.2 million (Q1 2025), $17.5 million (Q4 2024), and $18.2 million (Q3 2024), per Business Quant data.